Posted on 12 October 2016 in Clinical Trials
Screening patients into prodromal Alzheimer’s trials can be costly and time-consuming Kenton Zavitz, PhD, Director of Clinical Affairs & Rosemary Abbott, PhD, Principal Statistical Analyst look at a solution for improving recruitment into trials.
Posted on 5 October 2016 in Clinical Trials / Research
In this post, Director of Clinical Affairs, Dr Kenton Zavitz and Principal Statistical Analyst, Dr Rosemary Abbott look at the challenge of recruiting the correct patients into Alzheimer's disease trials.
Posted on 15 September 2016 in Research
Operational Scientist, Matthew Hobbs explores what test re-test reliability is, how you would measure it and why it is important when choosing cognitive tests.
Posted on 1 September 2016 in
Dr Jenny Barnett, Chief Scientific Officer for Cambridge Cognition reviews how the rise of touchscreen technology has enabled the expansion of cognitive assessment.
Posted on 5 May 2016 in Research
The early identification of individuals at risk of Alzheimer's Disease (AD) is of primary importance for the development of new effective interventions to stop the progression of the disease before the onset of severe neurodegeneration and clinical manifestations.
Posted on 15 March 2016 in Research
Brain Awareness Week aims to raise awareness of the progress and benefits of brain research, which CANTAB has contributed to for over 30 years.